The superior effects on EFS could be observed in the mice treated with DB in combination with FAP-IL-2v (Figure 7D), further underlining the improvement in anti-GD2 Ab immunotherapies by the immunocytokine FAP-IL-2v against NB. The gene discussed is FAP; the disease is neuroblastoma.